DE State Board of Pharmacy · Delaware

DE OTC Drug Marketing - State Board of Pharmacy

OTC drug marketing to Delaware consumers must keep claims within label or monograph uses, avoid absolute or unsupported comparative claims, and carry a Drug Facts panel on labels; ads need not repeat Drug Facts.

6 Del. C. § 2513(a); 15 U.S.C. § 52(a); 21 U.S.C. § 352(a); 21 C.F.R. § 201.66(c)

What is DE OTC Drug Marketing - State Board of Pharmacy?

OTC drug marketing to Delaware consumers must keep claims within label or monograph uses, avoid absolute or unsupported comparative claims, and carry a Drug Facts panel on labels; ads need not repeat Drug Facts. Apply to OTC drug ads, retailer pages, displays, packaging and labels reaching Delaware consumers.

US State

Read official source

Last reviewed: 2026-11-05

General information, not legal advice.

Who does this rule apply to?

general_audience, general_adults_18plus, customers · OTC Drug · pharma

Where does this rule apply?

Delaware · United States

Which marketing channels are covered?

all_channels

When does this rule take effect?

2026-05-10

What does this rule require?

OTC drug marketing to Delaware consumers must keep claims within label or monograph uses, avoid absolute or unsupported comparative claims, and carry a Drug Facts panel on labels; ads need not repeat Drug Facts.

How can marketing teams comply?

Apply to OTC drug ads, retailer pages, displays, packaging and labels reaching Delaware consumers.

Where can I read the official source?

Read official source

Key facts

Regulatory authority
DE State Board of Pharmacy
Jurisdiction
Delaware, United States
Official citation
6 Del. C. § 2513(a); 15 U.S.C. § 52(a); 21 U.S.C. § 352(a); 21 C.F.R. § 201.66(c)
Published
2026-11-16
Effective date
2026-05-10
Channel
all_channels
Products
OTC Drug
Audiences
general_audience, general_adults_18plus, customers

Frequently asked questions

What is DE OTC Drug Marketing - State Board of Pharmacy?

OTC drug marketing to Delaware consumers must keep claims within label or monograph uses, avoid absolute or unsupported comparative claims, and carry a Drug Facts panel on labels; ads need not repeat Drug Facts.

Who does this rule apply to?

general_audience, general_adults_18plus, customers · OTC Drug · pharma

Where does this rule apply?

Delaware · United States

Which marketing channels are covered?

all_channels

When does this rule take effect?

2026-05-10

Request a free compliance scan of your homepage and book a time with Warrant.

Get a free homepage compliance scan